Stock ZEOX ZEO SCIENTIFIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Zeo ScientifiX, Inc.

Equities

ZEOX

US68621D2062

Market Closed - OTC Markets
Other stock markets
 03:56:38 2024-04-19 pm EDT 		5-day change 1st Jan Change
1.35 USD -15.62% Intraday chart for Zeo ScientifiX, Inc. -15.62% +32.35%
Mar. 18 Zeo ScientifiX, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 CI
Mar. 05 Zeo ScientifiX, Inc. has Changed its Ticker to ZEOX from OCEL CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zeo ScientifiX, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024
CI
Zeo ScientifiX, Inc. has Changed its Ticker to ZEOX from OCEL
CI
Organicell Regenerative Medicine, Inc. will Change its Name to Zeo ScientifiX, Inc
CI
Organicell Regenerative Medicine, Inc. Reports Earnings Results for the Full Year Ended October 31, 2023
CI
Organicell Regenerative Medicine : Announces 1-for-200 Reverse Stock Split - Form 8-K
PU
Organicell Regenerative Medicine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023
CI
Organicell Regenerative Medicine, Inc. announced a financing transaction
CI
Organicell Regenerative Medicine : Acquisition/Asset Disposal - Form 8-K
PU
An unknown buyer acquired Laboratory Facility Located in Basalt, Colorado from Organicell Regenerative Medicine, Inc. for $1.25 million.
CI
Organicell Regenerative Medicine, Inc. Reports Interim Results of Phase 1/2A Research Program
CI
Organicell Regenerative Medicine, Inc. Announces Resignation of Maria Ines Mitrani as Director
CI
Organicell Welcomes Howard Golub as Its New EVP/CSO
CI
Organicell Regenerative Medicine, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023
CI
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Organicell Regenerative Medicine, Inc. Announces Executive Changes
CI
Organicell Regenerative Medicine, Inc. Announces Management Changes
CI
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
Organicell Regenerative Medicine, Inc. Terminates Albert Mitrani as Its Executive Vice President of Sales
CI
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
Organicell Regenerative Medicine, Inc. Announces Termination of Dr. Maria Ines Mitrani as its Chief Scientific Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZEOX Stock
  4. News Zeo ScientifiX, Inc.